Updates are available Correction dated 2022-12-09
Click to view Correction: https://doi.org/10.1186/s13046-022-02545-5
-
Authors
Jin, Dan
Guo, Jiwei https://orcid.org/0000-0003-1636-6499
Wu, Yan
Chen, Weiwei
Du, Jing
Yang, Lijuan
Wang, Xiaohong
Gong, Kaikai
Dai, Juanjuan
Miao, Shuang
Li, Xuelin
Su, Guoming
-
Funding
Funding for this research was provided by:
National Natural Science Foundation of China (31801085)
Natural Science Foundation of Shandong Province (ZR2018QH004)
Key Technology Research and Development Program of Shandong (2019GSF108174)
- License Information
-
More Information
Article History
Received: 8 October 2019
Accepted: 12 December 2019
First Online: 6 January 2020
Change Date: 9 December 2022
Change Type: Correction
Change Details: A Correction to this paper has been published:
Change Details: https://doi.org/10.1186/s13046-022-02545-5
Change Date: 27 February 2025
Change Type: Correction
Change Details: This article has been retracted. Please see the Retraction Notice for more detail:
Change Details: https://doi.org/10.1186/s13046-025-03331-9
Ethics approval and consent to participate
: The experimental protocol was approved by the Research Ethics Committee of Binzhou Medical University, China (No. 2018–018-01 for human lung cancer specimen and No. 2018–010-10 for mouse experiments in vivo) and the written informed consent was obtained from all subjects. Informed consent was obtained from all individual participants included in the study. All patients were staged based on the criteria of the 7th Edition of the AJCC Cancer Staging Manual (2010).
: The authors confirm that they have obtained written consent from each patient to publish the manuscript.
: The authors declare that they have no competing interests.
